AL
SLS icon

Airain Ltd’s SELLAS Life Sciences SLS Stock Holding History

Airain Ltd’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-57
Closed -$53K – 1025
2017
Q1 		$53K Buy
+57
New +$94.4K ﹤0.01% 769

Other funds holding SLS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Airain Ltd's SLS Position: Q2 2017 in Review

Airain Ltd sold out of SELLAS Life Sciences (SLS) in Q2 2017, closing a stake of 57 shares — an estimated $53K sold.

Airain Ltd first reported a position in SLS in Q1 2017 and held it in 1 quarter. The position peaked at $53K in Q1 2017. 34 funds tracked by Wall St. Rank hold SLS as of Q2 2017.

  • Airain Ltd reported no remaining SELLAS Life Sciences position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 57 SELLAS Life Sciences shares in Q2 2017, an estimated $53K.
  • Airain Ltd first reported a position in SELLAS Life Sciences in Q1 2017 and held it in 1 quarter.
  • Airain Ltd's SELLAS Life Sciences position peaked at $53K in Q1 2017.
  • 34 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.